| Literature DB >> 31173075 |
Dacotah Melicher1, Alex S Torson2,3, Tanner J Anderson2,4, George D Yocum1, Joseph P Rinehart1, Julia H Bowsher3.
Abstract
The response of ectotherms to temperature stress is complex, non-linear, and is influenced by life stage and previous thermal exposure. Mortality is higher under constant low temperatures than under a fluctuating thermal regime (FTR) that maintains the same low temperature but adds a brief, daily pulse of increased temperature. Long term exposure to FTR has been shown to increase transcription of genes involved in oxidative stress, immune function, and metabolic pathways, which may aid in recovery from chill injury and oxidative damage. Previous research suggests the transcriptional response that protects against sub-lethal damage occurs rapidly under exposure to fluctuating temperatures. However, existing studies have only examined gene expression after a week or over many months. Here we characterize gene expression during a single temperature cycle under FTR. Development of pupating alfalfa leafcutting bees (Megachile rotundata) was interrupted at the red-eye stage and were transferred to 6°C with a 1-h pulse to 20°C and returned to 6°C. RNA was collected before, during, and after the temperature pulse and compared to pupae maintained at a static 6°C. The warm pulse is sufficient to cause expression of transcripts that repair cell membrane damage, modify membrane composition, produce antifreeze proteins, restore ion homeostasis, and respond to oxidative stress. This pattern of expression indicates that even brief exposure to warm temperatures has significant protective effects on insects exposed to stressful cold temperatures that persist beyond the warm pulse. Megachile rotundata's sensitivity to temperature fluctuations indicates that short exposures to temperature changes affect development and physiology. Genes associated with developmental patterning are expressed after the warm pulse, suggesting that 1 h at 20°C was enough to resume development in the pupae. The greatest difference in gene expression occurred between pupae collected after the warm pulse and at constant low temperatures. Although both were collected at the same time and temperature, the transcriptional response to one FTR cycle included multiple transcripts previously identified under long-term FTR exposure associated with recovery from chill injury, indicating that the effects of FTR occur rapidly and are persistent.Entities:
Mesh:
Year: 2019 PMID: 31173075 PMCID: PMC6703998 DOI: 10.1093/icb/icz096
Source DB: PubMed Journal: Integr Comp Biol ISSN: 1540-7063 Impact factor: 3.326
Fig. 1mRNA sampling strategy for differential gene expression analysis during FTR pulse. Pupae were allowed to develop at 29°C until the red-eye pigmentation stage. mRNA was extracted from pupae prior to treatment (T0), during (T1), and after the warm pulse (T2). Pupae at 29°C were collected immediately prior to the temperature treatments (T0). Pupae were transferred to FTR and CT treatments. Pupae were collected at the end of a 1 h 20°C warm pulse (T1) and 2 h after returning to 6°C (T2). The 6°C CT treatment was also sampled at the T2 time point.
Fig. 2Summary of differential expression analysis of CT versus FTR treatments. Transcripts were identified as significant with a cutoff of α ≤ 0.05. The number of significant transcripts and the direction of expression were identified for all comparisons, with expression disproportionately up-regulated under FTR relative to CT (a), with the x-axis represented by the red arrow and the y-axis represented by the blue arrow. A dendrogram was constructed using the FPKM values of all annotated M. rotundata genes to determine the Jensen–Shannon distance between treatments and sample time points (b). Principle component analysis was performed on all genes (c) and the subset of significant genes (d).
Sequencing and mapping statistics
| Sample | Treatment | Reads | Mapped | Unmapped | ||
|---|---|---|---|---|---|---|
| T0-1 | FTR (29°C) | 37,062,935 | 27,531,929 | (74.3%) | 9,531,006 | (25.7%) |
| T0-2 | FTR (29°C) | 36,663,032 | 26,561,683 | (72.4%) | 10,101,349 | (27.6%) |
| T0-3 | FTR (29°C) | 37,589,676 | 25,144,257 | (66.9%) | 12,445,419 | (33.1%) |
| T1-1 | FTR (20°C) | 33,339,558 | 27,135,877 | (81.4%) | 11,981,208 | (35.9%) |
| T1-2 | FTR (20°C) | 39,256,402 | 29,176,358 | (74.3%) | 11,768,736 | (30.0%) |
| T1-3 | FTR (20°C) | 34,693,423 | 29,481,740 | (85.0%) | 12,791,732 | (36.9%) |
| T2-1 | FTR (6°C) | 39,939,573 | 27,576,476 | (69.0%) | 12,363,097 | (31.0%) |
| T2-2 | FTR (6°C) | 39,816,866 | 26,927, 100 | (67.6%) | 12,889,766 | (32.4%) |
| T2-3 | FTR (6°C) | 43,865,807 | 32,342,409 | (73.7%) | 11,523,398 | (26.3%) |
| CT-1 | CT (6°C) | 39,117,085 | 25,909,089 | (66.2%) | 7,430,469 | (19.0%) |
| CT-2 | CT (6°C) | 40,945,094 | 28,629,912 | (69.9%) | 10,626,490 | (26.0%) |
| CT-3 | CT (6°C) | 42,273,472 | 26,643,691 | (63.0%) | 8,049,732 | (19.0%) |
| Total | 464,562,923 | 333,060,521 | (71.7%) | 131,502,402 | (28.3%) | |
| Mean | 38,134,436 | 27,778,692 | 72.8% | 11,282,618 | (29.6%) | |
Notes: 126 base-pair paired-end Illumina reads were sequenced and mapped to the M. rotundata genome.
Fig. 3Expression of membrane component genes under FTR. Genes associated with membrane fluidity, lipid biosynthesis, and fatty acid modification are up-regulated (a) and down-regulated (b) during the warm pulse. During the warm pulse fatty acid synthase and fatty acid elongation enzymes are up-regulated and are down-regulated after the pulse with the exception of estradiol 17-beta-dehydrogenase 2 (a). Fatty acyl CoA, long-chain fatty acid transport protein 4, and a fatty acid elongation enzyme are down-regulated (b). T0-T2 represent expression over time under FTR versus CT.
Fig. 4Expression of membrane components under CT and expression of CRAL-TRIO family enzymes. Some genes that affect membrane composition are significantly up-regulated under CT but are not affected by the warm pulse (a). CRAL-TRIO genes, intracellular membrane-bound transporters that affect fluidity by exchanging phospholipids, are differentially expressed at T1 or T2 versus CT (b). T0-T2 represent expression over time under FTR versus CT.
Fig. 5Antioxidant and antifreeze response to FTR. Glutathione synthase is down-regulated under FTR. Glutathione transferase expression declines under FTR and is not significantly different between T2 and CT. Peroxiredoxin-6 is up-regulated during the warm pulse and glutaredoxin expression increases after the pulse. Peroxidases and peroxisome biogenesis factor 2 are differentially expressed between FTR and CT treatments (a). Antifreeze protein Maxi-like is differentially expressed at T0 and T1 versus CT. Trehalose transporters are regulated in opposing directions. Expression of the temperature-associated chaperone samui is significantly different at T2 versus CT (b). T0-T2 represent expression over time under FTR versus CT.
Fig. 6Ion channel, chitinase, and cuticle protein expression during FTR. Ion channel proteins respond to the warm pulse and are significantly down-regulated versus CT (a). Chitinase, chitin-binding proteins, and cuticle proteins are differentially expressed between FTR and CT treatments although the mechanism and function of this response is unknown (b). T0-T2 represent expression over time under FTR versus CT.
Protein function annotation clustering of significant transcripts
| Function summary |
| χ2 |
| ES |
|---|---|---|---|---|
| Lipid metabolism | 8 | 84.97 | <0.0001* | 2.05 |
| Chitin binding | 9 | 43.18 | <0.0001* | 1.88 |
| Transcription, DNA-binding, HOX genes | 43 | 234.9 | <0.0001* | 1.12 |
| Pyridoxal phosphate binding | 5 | 25.24 | 0.005* | 1.1 |
| CRAL-TRIO binding domain | 3 | 14.62 | 0.023* | 1.06 |
| Membrane components | 49 | 17.06 | 0.029* | 0.17 |
| Serine protease | 3 | 23.73 | 0.095 | 0.64 |
| Glycoside hydrolase | 3 | 8.86 | 0.35 | 0.48 |
| Protein kinase activity | 26 | 26.47 | 0.33 | 0.48 |
| Major facilitator superfamily | 7 | 6.47 | 0.37 | 0.47 |
| Leucine-rich repeat | 5 | 5.28 | 0.51 | 0.38 |
Notes: All differentially expressed transcripts were clustered by InterPro protein features and functions. Clusters with similar functions were combined to summarize overall transcript function with n representing the number of unique transcript identities in each group. χ and P-values use Fisher’s method for testing combined probability to determine significance. ES indicates combined enrichment scores by weighted mean.
Pathway enrichment of significant differentially expressed transcripts
| Comparison | Term | Description | FE |
|
| |
|---|---|---|---|---|---|---|
| T0 (29°C) vs. CT (6°C) | ame00360 | Phenylalanine metabolism | ↑ | 70.43 | 2 | 0.023 |
| ame00350 | Tyrosine metabolism | ↑ | 46.96 | 2 | 0.035 | |
| T1 (20°C) vs. CT (6°C) | ame00604 | Glycosphingolipid biosynthesis | ↓ | 105.65 | 2 | 0.016 |
| ame00531 | Glycosaminoglycan degradation | ↓ | 40.63 | 2 | 0.042 | |
| ame00511 | Other glycan degradation | ↓ | 37.73 | 2 | 0.046 | |
| T2 (6°C) vs. CT (6°C) | None | |||||
| T0 (29°C) vs. T1 (20°C) | ame01100 | Metabolic pathways | ↑ | 2.18 | 7 | 0.034 |
| ame00360 | Phenylalanine metabolism | ↑ | 42.26 | 2 | 0.042 | |
| ame01212 | Fatty acid metabolism | ↓ | 28.55 | 2 | 0.05 | |
| T1 (20°C) vs. T2 (6°C) | None | |||||
| T0 (29°C) vs. T2 (6°C) | ame01100 | Metabolic pathways | ↑ | 3.12 | 5 | 0.01 |
| ame00360 | Phenylalanine metabolism | ↑ | 84.52 | 2 | 0.019 | |
| ame00380 | Tryptophan metabolism | ↑ | 36.75 | 2 | 0.043 |
Notes: KEGG pathway enrichment using A. mellifera orthologs. Enrichment was determined by mapping up-regulated or down-regulated transcripts to KEGG pathways for each comparison with a cutoff of α ≤ 0.05. The direction of expression is indicated by the arrow, with FE, and the number (n) of unique transcripts mapping to each pathway.
GO term enrichment of significant differentially expressed transcripts under FTR versus CT
| Sample | Term | Description | FE |
|
| ||
|---|---|---|---|---|---|---|---|
| T0 (29°C) | |||||||
| BP | GO: 0016021 | Aromatic amino acid metabolic process | ↑ | 82.18 | 2 | 0.022 | |
| MF | GO: 0042302 | Structural constituent of cuticle | ↑ | 16.56 | 5 | <0.001 | |
| MF | GO: 0005506 | Iron ion binding | ↑ | 8.03 | 3 | 0.05 | |
| BP | GO: 0006633 | Fatty acid biosynthetic process | ↓ | 31.8 | 3 | <0.01 | |
| MF | GO: 0102337 | 3-oxo-cerotoyl-CoA synthase activity | ↓ | 80.88 | 3 | <0.001 | |
| T1 (20°C) | |||||||
| BP | GO: 0006355 | Regulation of transcription | ↑ | 7.74 | 7 | <0.0001 | |
| CC | GO: 0005634 | Nucleus | ↑ | 2.73 | 7 | 0.028 | |
| MF | GO: 0042302 | Structural constituent of cuticle | ↑ | 16.56 | 5 | <0.001 | |
| MF | GO: 0043565 | Sequence-specific DNA binding | ↑ | 4.56 | 5 | 0.02 | |
| MF | GO: 0030170 | Pyridoxal phosphate binding | ↓ | 21.85 | 3 | <0.01 | |
| T2 (6°C) | |||||||
| BP | GO: 0006355 | Regulation of transcription | ↑ | 5.05 | 6 | 0.004 | |
| MF | GO: 0043565 | Sequence-specific DNA binding | ↑ | 5.01 | 6 | <0.01 | |
| BP | GO: 0006633 | Fatty acid biosynthetic process | ↓ | 28.62 | 3 | <0.01 | |
| BP | GO: 0006355 | Regulation of transcription | ↓ | 59.31 | 3 | <0.001 |
Notes: GO term enrichment of FTR versus CT treatments with a cutoff of α ≤ 0.05. Direction of expression under FTR is indicated by the arrow. The number of transcripts (n) and FE are shown for each term.
GO term enrichment of significant differentially expressed transcripts under FTR
| Comparison | Term | Description | FE |
|
| ||
|---|---|---|---|---|---|---|---|
| T0 (29°C) vs. T1 (20°C) | |||||||
| CC | GO: 0016021 | Integral component of membrane | ↑ | 1.63 | 12 | 0.017 | |
| MF | GO: 0030170 | Pyridoxal phosphate binding | ↑ | 21.85 | 3 | <0.01 | |
| MF | GO: 0080019 | fatty-acyl-CoA reductase activity | ↑ | 69.2 | 2 | 0.026 | |
| BP | GO: 0006633 | Fatty acid biosynthetic process | ↓ | 19.08 | 3 | <0.01 | |
| BP | GO: 0006355 | Regulation of transcription, DNA-templated | ↓ | 4.72 | 4 | 0.04 | |
| T1 (20°C) vs. T2 (6°C) | |||||||
| BP | GO: 0006633 | Fatty acid biosynthetic process | ↑ | 40.88 | 0.002 | ||
| MF | GO: 0102337 | 3-oxo-cerotoyl-CoA synthase activity | ↑ | 74.14 | 3 | <0.001 | |
| MF | GO: 0102336 | 3-oxo-arachidoyl-CoA synthase activity | ↑ | 74.14 | 3 | <0.001 | |
| MF | GO: 0102338 | 3-oxo-lignoceronyl-CoA synthase activity | ↑ | 74.14 | 3 | <0.001 | |
| MF | GO: 0080019 | fatty-acyl-CoA reductase activity | ↓ | 148.28 | 2 | 0.012 | |
| T0 (29°C) vs. T2 (6°C) | |||||||
| MF | GO: 0030170 | Pyridoxal phosphate binding | ↑ | 31.22 | 2 | 0.05 | |
Notes: Enrichment of GO terms across FTR time points with a cutoff of α ≤ 0.05. Direction of expression in each comparison is indicated by the arrow. The number of transcripts (n) and FE are shown for each term.
Protein function enrichment of significant transcripts under FTR versus CT
| Sample | Term | Description | FE |
|
| |
|---|---|---|---|---|---|---|
| T0 (29°C) | ||||||
| IPR000618 | Insect cuticle protein | ↑ | 16.47 | 5 | <0.001 | |
| IPR001273 | Aromatic amino acid hydroxylase | ↑ | 125.14 | 2 | 0.017 | |
| IPR019773 | Tyrosine 3-monooxygenase-like | ↑ | 125.14 | 2 | 0.017 | |
| IPR018301 | Aromatic amino acid hydroxylase, iron/copper | ↑ | 125.14 | 2 | 0.017 | |
| IPR002076 | GNS1/SUR4 membrane protein | ↓ | 86.4 | 3 | <0.001 | |
| T1 (20°C) | ||||||
| IPR000618 | Insect cuticle protein | ↑ | 17.69 | 5 | <0.001 | |
| IPR013087 | Zinc finger C2H2-type/integrase DNA-binding | ↑ | 4.73 | 5 | 0.02 | |
| IPR001680 | WD40 repeat | ↑ | 4.48 | 5 | 0.023 | |
| IPR001507 | Zona pellucida domain | ↓ | 52.79 | 2 | 0.036 | |
| T2 (6°C) | ||||||
| IPR013087 | Zinc finger C2H2-type/integrase DNA-binding | ↑ | 3.93 | 5 | 0.036 | |
| IPR002076 | GNS1/SUR4 membrane protein | ↓ | 62.21 | 3 | <0.001 | |
| IPR010562 | Hemolymph juvenile hormone binding | ↓ | 41.47 | 2 | 0.045 |
Notes: Enrichment of InterPro protein functions/features between FTR and CT treatments with a cutoff of α ≤ 0.05. Direction of expression under FTR is indicated by the arrow. The number of transcripts (n) and FE are shown for each term.
Protein function enrichment of significant transcripts under FTR
| Comparison | Term | Description | FE |
|
| |
|---|---|---|---|---|---|---|
| T0 (29°C) vs. T1 (20°C) | ||||||
| IPR015422 | Pyridoxal phosphate-dependent transferase | ↑ | 20.74 | 3 | <0.01 | |
| IPR013120 | Male sterility, NAD-binding | ↑ | 60.48 | 2 | 0.03 | |
| IPR026055 | Fatty acyl-CoA reductase | ↑ | 60.48 | 2 | 0.03 | |
| IPR002076 | GNS1/SUR4 membrane protein | ↓ | 51.84 | 3 | 0.001 | |
| IPR001356 | Homeodomain | ↓ | 12.1 | 4 | <0.01 | |
| IPR017970 | Homeobox, conserved site | ↓ | 10.67 | 3 | 0.03 | |
| T1 (20°C) vs. T2 (6°C) | ||||||
| IPR002076 | GNS1/SUR4 membrane protein | ↑ | 77.76 | 3 | <0.001 | |
| IPR010562 | Hemolymph juvenile hormone binding | ↑ | 77.76 | 3 | <0.001 | |
| IPR001611 | Leucine-rich repeat | ↑ | 12.23 | 3 | 0.022 | |
| IPR016040 | NAD(P)-binding domain | ↓ | 19.67 | 5 | <0.0001 | |
| IPR002347 | Glucose/ribitol dehydrogenase | ↓ | 37.22 | 3 | 0.002 | |
| IPR013120 | Male sterility, NAD-binding | ↓ | 120.97 | 2 | 0.015 | |
| IPR026055 | Fatty acyl-CoA reductase | ↓ | 120.97 | 2 | 0.015 | |
| T0 (29°C) vs. T2 (6°C) | ||||||
| IPR020846 | Major facilitator superfamily domain | ↓ | 19.2 | 3 | 0.008 | |
| IPR013761 | Sterile alpha motif/pointed domain | ↓ | 57.6 | 2 | 0.03 | |
| IPR005828 | General substrate transporter | ↓ | 37.51 | 2 | 0.046 | |
Notes: Enrichment of InterPro protein functions/features across FTR time points with a cutoff of α ≤ 0.05. Direction of expression in each comparison is indicated by the arrow. The number of transcripts (n) and FE are shown for each term.
Selected differentially expressed transcripts across FTR studies
| Gene set | RefSeq-RNA | Short name | Gene name |
|---|---|---|---|
|
| |||
| XM_003708250 | LOC100881147 | BAG domain-containing protein Samui-like | |
| XM_003708002 | LOC100877637 | Serine/threonine-protein kinase SIK3-like | |
| XM_003699760 | LOC100880515 | Bone morphogenetic protein receptor type-1B | |
| XM_012282783 | LOC100881489 | Nuclear hormone receptor FTZ-F1 | |
| XM_012281076 | LOC105661976 | CCAAT/enhancer-binding protein-like | |
|
| |||
| XM_012288926 | LOC100880270 | Transmembrane protease serine 9-like | |
| XM_003700471 | LOC100877574 | Elongation of very long chain fatty acids protein 7-like | |
| XM_003703558 | LOC100878819 | Fatty acid synthase | |
| XM_003700398 | LOC100878398 | Heparan-alpha-glucosaminide N-acetyltransferase-like | |
| XM_012292966 | LOC100880205 | Phosphodiesterase epsilon-1-like | |
| XM_003702488 | LOC100880638 | Aquaporin AQPcic-like | |
| XM_003703107 | LOC100875155 | Peroxiredoxin-6-like | |
| XM_003704386 | LOC100879301 | Alpha-amylase-like | |
| XM_003702306 | LOC100879369 | Carboxypeptidase M-like | |
| XM_012287600 | LOC100882780 | Serine proteinase stubble | |
| XM_003701259 | LOC100882217 | Protein yellow-like | |
| XM_003704962 | LOC100880044 | Transmembrane domain-containing protein 2-like | |
| XM_012286750 | LOC100881714 | Acyl-CoA Delta | |
| XM_003702234 | LOC100880821 | Glutamic acid-rich protein | |
| XM_003707059 | LOC100879468 | Phenoloxidase 2 | |
| XM_012286098 | LOC105662570 | Histidine-rich glycoprotein-like | |
| XM_012284520 | LOC100877204 | Vitellogenin-like | |
| XM_012284233 | LOC100878705 | Facilitated trehalose transporter Tret1-like | |
|
| |||
| XM_003700977 | LOC100878060 | Hemolymph lipopolysaccharide-binding protein-like | |
| XM_003700471 | LOC100877574 | Elongation of very long chain fatty acids protein 7-like | |
| XM_003704386 | LOC100879301 | Alpha-amylase-like | |
| XM_003700707 | LOC100875958 | Cytochrome P450 4g15-like | |
|
| |||
| XM_003702880 | LOC100878030 | Aminomethyltransferase, mitochondrial | |
| XM_003706384 | LOC100877030 | Aminotransferase, mitochondrial-like | |
| XM_003700707 | LOC100875958 | Cytochrome P450 4g15-like | |
| XM_003703558 | LOC100878819 | Fatty acid synthase | |
|
| |||
| None | |||
|
| |||
| XM_003702196 | LOC100876503 | Mitochondrial amidoxime-reducing component 1 | |
| XM_003707130 | LOC100877705 | Beta-galactosidase-like | |
| XM_012286145 | LOC100882514 | Peroxidase-like | |
| XM_003702880 | LOC100878030 | Aminomethyltransferase, mitochondrial | |
| XM_003700707 | LOC100875958 | Cytochrome P450 4g15-like | |
| XM_012283276 | LOC100879483 | Sterol | |
Notes: Differentially expressed transcripts were retrieved from Torson et al. (2015, 2017) and annotated by sequence alignment to the current genome release (Torson et al. 2015, 2017). Significant transcripts shared between studies are summarized here.